Ingalls & Snyder LLC Haleon PLC Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Haleon PLC stock. As of the latest transaction made, Ingalls & Snyder LLC holds 30,665 shares of HLN stock, worth $314,009. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,665
Previous 31,665
3.16%
Holding current value
$314,009
Previous $335,000
12.54%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding HLN
# of Institutions
664Shares Held
417MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.83 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$336 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$247 Million1.6% of portfolio
-
Morgan Stanley New York, NY9.89MShares$101 Million0.01% of portfolio
-
Sculptor Capital LP New York, NY8.89MShares$91 Million2.49% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...